Related Experiment Video
Updated: Apr 13, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Therapeutic hypothermia in patients with out-of-hospital arrest
Annette M Maznyczka1, Anthony H Gershlick2
1Cardiovascular Division, King's College London, London, UK.
Insights
Therapeutic hypothermia (TH) may improve outcomes for cardiac arrest patients with specific rhythms. However, evidence is limited, and optimal use of TH for out-of-hospital cardiac arrest (OHCA) remains uncertain.
Area of Science:
- Cardiology
- Neurology
- Critical Care Medicine
Background:
- Therapeutic hypothermia (TH) is increasingly used for out-of-hospital cardiac arrest (OHCA).
- Existing data suggest TH may improve survival and neurological outcomes post-cardiac arrest.
- TH is incorporated into OHCA management guidelines, especially for ST-elevation myocardial infarction.
Purpose of the Study:
- To review the current evidence and status of therapeutic hypothermia in OHCA patients.
- To address the uncertainty surrounding the true impact of TH on patient outcomes.
- To highlight the need for more robust trials to inform clinical guidelines.
Main Methods:
- Review of current literature and clinical trial data on therapeutic hypothermia in OHCA.
- Analysis of evidence stratified by initial cardiac arrest rhythm (asystole, PEA, VF/VT).
- Examination of ongoing debates regarding optimal TH temperature and timing.
Main Results:
- Evidence suggests TH does not improve survival or neurological outcomes in OHCA patients with asystole or pulseless electrical activity (PEA).
- Observational and small randomized studies indicate potential survival and neurological benefits for OHCA patients with ventricular fibrillation (VF) or ventricular tachycardia (VT).
- The robustness of trial data for VF/VT is questioned, with ongoing debate on optimal TH protocols.
Conclusions:
- More uniform and robust guidelines for TH in OHCA are needed.
- The formulation of definitive guidelines requires appropriately sized, high-quality clinical trials.
- Current evidence on the efficacy of TH in OHCA remains inconclusive, particularly regarding optimal temperature and timing.
Abstract:
Therapeutic hypothermia (TH) is increasingly used in patients presenting with out-of-hospital cardiac arrest (OHCA). Such strategies derive from data that suggest TH may improve survival and attenuate adverse neurological outcomes associated with the cardiac arrest. Consequently, TH has been integrated into various guidelines for the management of OHCA and has become a focussed strategy, particularly in patients with ST-segment elevation myocardial infarction. However, there remains uncertainty over the true impact of TH. In patients with OHCA due to asystole or pulseless electrical activity, overall available evidence suggests that TH does not improve neurological outcomes and survival. While in patients with OHCA due to ventricular fibrillation or ventricular tachycardia, observational studies and small, randomised studies have suggested there may be survival benefits and improved neurological recovery. However, even here, trial data robustness has been questioned, with ongoing debate regarding the optimum temperature for managing patients with OHCA and optimal timing of its initiation. More uniform and robust guidelines for the application of TH for patients with OHCA are required, but can only be formulated on appropriately sized robust trials. This review examines the current status of TH.
Related Concept Videos
Decreased Body Temperature
Cardiopulmonary Resuscitation IV: Pharmacological Management
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Cardiopulmonary Resuscitation I: Adult

